These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9378490)

  • 1. An essential role for endogenous interferon-gamma in the generation of protective T cells against Mycobacterium bovis BCG in mice.
    Yang J; Mitsuyama M
    Immunology; 1997 Aug; 91(4):529-35. PubMed ID: 9378490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-gamma-producing ability as a possible marker for the protective T cells against Mycobacterium bovis BCG in mice.
    Kawamura I; Tsukada H; Yoshikawa H; Fujita M; Nomoto K; Mitsuyama M
    J Immunol; 1992 May; 148(9):2887-93. PubMed ID: 1374103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen provoking gamma interferon production in response to Mycobacterium bovis BCG and functional difference in T-cell responses to this antigen between viable and killed BCG-immunized mice.
    Kawamura I; Yang J; Takaesu Y; Fujita M; Nomoto K; Mitsuyama M
    Infect Immun; 1994 Oct; 62(10):4396-403. PubMed ID: 7927701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
    Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
    Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of the initial production of gamma interferon in the generation of protective immunity of mice against Listeria monocytogenes.
    Yang J; Kawamura I; Mitsuyama M
    Infect Immun; 1997 Jan; 65(1):72-7. PubMed ID: 8975894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of natural killer cells in nitric oxide production by spleen cells after stimulation with Mycobacterium bovis BCG. Study of the mechanism of the different abilities of viable and killed BCG.
    Yang J; Kawamura I; Zhu H; Mitsuyama M
    J Immunol; 1995 Dec; 155(12):5728-35. PubMed ID: 7499860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of mouse strain and vaccine viability on T-cell responses induced by Mycobacterium bovis bacillus Calmette-Guérin.
    Daugelat S; Ladel CH; Kaufmann SH
    Infect Immun; 1995 May; 63(5):2033-40. PubMed ID: 7537253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary immune responses during primary mycobacterium bovis- Calmette-Guerin bacillus infection in C57Bl/6 mice.
    Fulton SA; Martin TD; Redline RW; Henry Boom W
    Am J Respir Cell Mol Biol; 2000 Mar; 22(3):333-43. PubMed ID: 10696070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guérin.
    Sakai S; Kawamura I; Okazaki T; Tsuchiya K; Uchiyama R; Mitsuyama M
    Int Immunol; 2010 Dec; 22(12):915-25. PubMed ID: 21047981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis.
    Hwang SA; Kruzel ML; Actor JK
    Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
    Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
    Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon.
    Wozniak TM; Saunders BM; Ryan AA; Britton WJ
    Infect Immun; 2010 Oct; 78(10):4187-94. PubMed ID: 20679438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of interferon-gamma production in killed BCG-pretreated mice after stimulation with staphylococcal enterotoxin A].
    Mizukoshi N; Ishihara C; Yamamoto K; Kato K
    Kekkaku; 1989 Aug; 64(8):499-509. PubMed ID: 2509777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
    Kim A; Hur YG; Gu S; Cho SN
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule.
    Luo Y; Jiang W; Da Z; Wang B; Hu L; Zhang Y; An R; Yu H; Sun H; Tang K; Tang Z; Wang Y; Jing T; Zhu B
    Scand J Immunol; 2012 Mar; 75(3):293-300. PubMed ID: 22117839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-
    Rivas-Santiago CE; Guerrero GG
    Biomed Res Int; 2017; 2017():8796760. PubMed ID: 29090221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.